In 1978, I wrote a letter to Ben Lewin, then editor of Cell, asking him to consider two manuscripts on the biochemical properties of the infectious particle causing experimental scrapie in mice. We had learned that the infectious scrapie particles could acquire a wide variety of sizes and that this behavior could not be altered by detergents or salts under conditions that preserved infectivity. We concluded that this non-ideal behavior was the result of hydrophobic interactions (Prusiner et al., 1978a (Prusiner et al., , 1978b . The experiments had taken nearly four years to perform. Indeed, the work was heroic, but I knew that it was correct because we had repeated the work at least once and often twice so that I was confident of the results.
Needless to say, I was sad when Ben Lewin responded with a recommendation that we send him a paper once we had purified the scrapie agent. It was as if he ignored the challenges that our findings presented. At that time, it was clear that the physical properties of the scrapie agent were sufficiently non-ideal as to herald a biochemical nightmare. We were to struggle for the next four years before we discovered the protein of the scrapie agent in 1982. By that time, it seemed highly likely that the infectious particle causing scrapie was not a slow acting virus, which was the favored hypothesis. To distinguish the scrapie agent from viruses, I suggested that the term "prion" might be more appropriate in describing these novel proteinaceous infectious particles (Prusiner, 1982) .
The discovery of the prion protein (PrP) occurred only after we developed an incubation-time assay that accelerated almost 100-fold our efforts directed toward purification of the scrapie agent Prusiner et al., 1980 Prusiner et al., , 1982 . Once we were able to produce the purified protein PrP 27-30 in large quantities , we were in a position to probe more extensively the issue of whether or not PrP 27-30 was an essential component of the infectious particle. After radiolabeling purified fractions with 1251, we found that one protein, PrP 27-30, was the predominant iodinated molecule.
With r2~l]-PrP 27-30 available, we decided to investigate the kinetics of PrP 27-30 and the degradation of infectivity . We wanted to know whether degradation of the protein and infectivity were coincident or divergent. As described in the article by McKinley et al., we were unable to separate PrP 27-30 from prion infectivity. The kinetics of PrP 27-30 proteolysis catalyzed by proteinase K were indistinguishable from the diminution of prion infectivity as determined by incubation-time bioassays performed in Syrian hamsters. Although PrP 27-30 and infectivity were stable for 2 hr in the presence of proteinase K, longer digestions diminished both the protein and the prion titer. Prolonged digestion with either trypsin or SV-8 had no effect on PrP 27-30 or infectivity.
We concluded that the results of these studies provided evidence in support of our postulate that PrP 27-30 is an essential and, perhaps, the sole, component of the infectious prion particle. Now we had what I thought was likely to be a Cell paper. After hastily preparing the manuscript, we sent it to Cell and were delighted when Ben Lewin accepted the paper with, of course, some revisions. Another decade was to pass before enough data would be gathered using many independent disciplines to build compelling evidence on the composition of prions (Prusiner, 1991 (Prusiner, , 1998 .
